DNTH (dianthustx.com) Bozor qiymatining balans qiymatiga nisbati
Dianthus Therapeutics (DNTH) tomonidan innovatsion biologik vositalarning ishlab chiqilishi molekulyar patentlarga tayanadi, bu esa sinovlarning murakkabligi va qat'iy nazorat tufayli ulkan investitsiyalarni talab qiladi. Jori ko'rsatkich 3.75 hisoblanadi. O'sish potentsiali noyob patologiyalarga chalingan bemorlar orasida talabning shakllanishiga asoslangan. Aktivning bazaviy baholashiga yordam beradigan ushbu narxlar grafigi, klinik ustunlik uchun sanoat gigantlari bilan yuqori xavfli kurash olib borayotgan kompaniyaning mavqeini namoyish etadi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_DNTH_-_Dianthus-Therapeutics_-_Market-Capitalization-to-Net-Assets "DNTH Dianthus Corp Bozor kapitallashuvining balans qiymatiga nisbati (21.02.2024 - 28.10.2026) | 👁️GURU.Markets👁️")
Dianthus Therapeutics Inc (DNTH) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Dianthus Therapeutics|DNTH - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Dianthus Pharma|DNTH - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Dianthus Pharma|DNTH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Dianthus Therapeutics
Kompaniyaning dastlabki tahlili:Dianthus Therapeutics - DNTH
Fundamental xatarlarni minimallashtirish uchun investorlar bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbatini hisobga olgan holda sof aktivlarning bir dollari qiymatini baholaydilar. Ushbu narxning buxgalteriya qiymatiga nisbati moddiy aktivlardan yuqori bo'lgan bozor premiumini o'lchaydi, bu esa Dianthus Therapeutics (DNTH) sog'liqni saqlash giganti sektorida minimal ekologik muvofiqlik xarajatlari bilan bir qatorda intellektual kapital va immunologik ishlanmalarga bo'lgan ishonchni aks ettiradi.
Asosiy raqobatchilar
Bozor kapitallashuvining balans qiymatiga nisbati argenx SE ARGX|BNTX (biontech.de) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pharvaris.com (PHVS)|AbCellera Bio (ABCL) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Tourmaline Bio Inc (TRML)|Bozor kapitallashuvining balans qiymatiga nisbati PGEN|Pharming Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|NKTR: Bozor qiymatining balans qiymatiga nisbati|UPB: Kapitallashuvning sof aktivlarga nisbati|ZBIO (Zenas Biopharma) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Immunome Inc|GOSS (Gossamer Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati KALV|Bozor qiymatining balans qiymatiga nisbati Septerna Inc SEPN|Kapitallashuvning balans qiymatiga nisbati pieris.com (PVLA)|SVRA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Rigel Pharma RIGL|AnaptysBio Corp (ANAB) - Bozor kapitallashuvining balans qiymatiga nisbati|ATXS - Kapitallashuvning balans qiymatiga nisbati|enGene Holdings Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|rapt.com (RAPT) - Balans qiymatiga nisbatan bozor kapitallashuvi|JBIO (Aerovate Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ACRS|Bozor qiymatining balans qiymatiga nisbati Kyverna KYTX|Kapitallashuvning balans qiymatiga nisbati Tiziana Life Sciences, Ltd. TLSA|Kapitallashuvning sof aktivlarga nisbati Cabaletta Bio, Inc. (CABA)|Bozor kapitallashuvining balans qiymatiga multiplikatori ventyxbio.com VTYX|Bozor kapitallashuvining balans qiymatiga nisbati Theratechnologies (THTX)|Avalo Therapeutics, Inc. (AVTX) - Balans qiymatiga nisbatan bozor qiymati|ELDN: Kapitallashuvning sof aktivlarga nisbati|AGEN (Agenus, Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|CLYM: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi zurabio.com (ZURA)|aTyr Pharma (ATYR) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati adagene.com ADAG|Kapitallashuvning sof aktivlarga nisbati Ikena Oncology (IMA)|Bozor kapitallashuvining balans qiymatiga multiplikatori Shattuck Labs Inc STTK|Bozor kapitallashuvining balans qiymatiga nisbati Equillium Bio (EQ)|CNTB - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati IMUX|ATRA (Atara Bio) - Bozor qiymatining balans qiymatiga koeffitsiyenti|IFRX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati X4 Pharmaceuticals, Inc|Bozor kapitallashuvining balans qiymatiga nisbati ACET|Bozor kapitallashuvining balans qiymatiga nisbati CELU (celularity.com)|INmune Bio (INMB) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Barinthus Biotherapeutics PLC BRNS|KZR (Kezar Life Sciences, Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|SAB Biotherapeutics Inc (SABS) - Bozor qiymatining balans qiymatiga koeffitsiyenti|AKTX: Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Enlivex Therapeutics Ltd.|Q32 Bio Inc (QTTB) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori GeoVax Labs|EDSA (Edesa) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi iBio Corporation (IBIO)|Carisma Therapeutics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|xtlbio.com - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati BOLT (Bolt Bio)|HCWB - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati aptevotherapeutics.com|AIM (aimimmuno.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc. (ADTX)|Kapitallashuvning balans qiymatiga nisbati gribio.com (GRI)|Kapitallashuvning sof aktivlarga nisbati XORTX Therapeutics|Bozor kapitallashuvining balans qiymatiga multiplikatori Vyome Holdings Inc. (HIND)|Bozor kapitallashuvining balans qiymatiga nisbati Revelation Bio|Indaptus Corp - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Scinai Immunotherapeutics|CALI - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati affimed.com AFMD|Allakos (ALLK) - Balans qiymatiga nisbatan bozor qiymati|HOOK (HOOKIPA Pharma, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IGMS|iTeos Therapeutics (ITOS) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati OCEA (oceanbiomedical.com)|TC BioPharm - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Third Harmonic Bio Inc. THRD